Home›Stock Screener›Concord Biotech›P/E Ratio

Concord Biotech P/E Ratio

Current P/E Ratio
51.32
High Valuation
Very High - High growth expectations or significantly overvalued

Concord Biotech P/E ratio. Concord Biotech (CONCORDBIO) P/E ratio is 51.32 (High), EPS (TTM) ₹24.78, current price ₹1270.70 on NSE vs historical average P/E of 50.69 (66.7th percentile) — Very High - High growth expectations or significantly overvalued. Also explore CONCORDBIO share price charts to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 51.32
Current Price ₹1270.70
EPS (TTM) ₹24.78
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 50.69
Historical Range 32.39 - 72.25
Percentile 66.7%

Sector Context

Sector Average 54.84
Sector Median 31.69
Sector Rank #11 of 200
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹33.43
Mar 2026 ₹8.46
Jun 2026 ₹5.52

CONCORDBIO P/E Ratio — Valuation Signal & Historical Context

Concord Biotech P/E 51.32 vs historical average 50.69, range 32.39–72.25 — signal: Overvalued. Examine Concord Biotech quarterly earnings for recent quarterly revenue, profit and EPS trends.

  • Stock appears overvalued with PE of 51.32, suggesting caution for new investments

Concord Biotech P/E Ratio Historical Trend

CONCORDBIO annual price-to-earnings ratio — 3 years, EPS and year-end price. Current P/E 51.32 vs historical average 50.69. For live price, revenue and the complete fundamental profile, see Concord Biotech share price chart.

CONCORDBIO Historical P/E Ratio — EPS, Year-End Price & Valuation

Concord Biotech annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 72.25 29.74 ₹2148.75 NSE High
2024 47.43 31.19 ₹1479.40 NSE High
2023 32.39 29.11 ₹942.80 NSE High

CONCORDBIO vs Healthcare Peers — P/E Ratio Comparison

Concord Biotech P/E 51.32 vs Healthcare average 54.84, median 31.69 — range 2.02–722.21.

Sector Average
54.84
Sector Median
31.69
Lowest P/E
2.02
Highest P/E
722.21
Companies
200
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.02 ₹60 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.33 ₹55 Low
Sun Pharma Advanced Rese… SPARC 3.86 ₹6,006 Low
Dipna Pharmachem DPL 3.97 ₹11 Low
JFL Life Sciences JFLLIFE 5.05 ₹65 Low
Royal Sense ROYAL 5.39 ₹40 Low
Kabra Drugs KABRADG 5.47 ₹41 Low
GKB Ophthalmics GKB 5.85 ₹32 Low
Colinz Laboratories COLINZ 6.31 ₹18 Low